|
|
|
| Educational Objectives |
|
|
This program is
accredited for 16 AMA PRA
Category 1 Credits™. Upon completion of this
program, participants
should be able to:
|
Day 1:
- Recognize unusual presentations of Sweet’s syndrome
- Critically analyze efficacy and safety data on new psoriasis medications
- Interpret systemic manifestations of acneiform eruptions
- Recognize the interaction between microbes and atopic dermatitis in children
- Describe new evidence regarding the biology of acne & rosacea
- Catalog the evolving common allergens responsible for contact dermatitis
- Describe and explore uses of new treatments for autoimmune bullous disease
Day 2:
- Explore treatment options for unusually high-risk non-melanoma skin cancers
- Effectively plan treatment protocols for patients with cutaneous lymphomas
- Employ evidence-based guidelines for the treatment of melanoma
- Distinguish between different filler agents and use them effectively and safely
- Describe the scientific basis for aesthetic treatments
Day 3:
- Compare the approaches of dermatologists and gynecologists in working up and treating vulvar dermatoses
- Distinguish the relative safety of dermatologic medications for use in pregnant women, and describe the limitations of the FDA pregnancy classification system
- Critically analyze new evidence regarding vitamin D deficiency and its possible effects or non-effects, and the impact of sunscreens on vitamin D
- Describe the approaches to alopecias in patients of various ethnicities
- Effectively work up and treat disorders of pigmentation
|
|
|
Return to Dermatology Foundation Home Page
Printer Friendly Page
|
|
|
|
|
|